ArticlePloS one2024
Proportion of foetal and placental implantation abnormalities in Madagascar: A cross-sectional study of 35,919 women at public-sector primary healthcare facilities in central and southern Madagascar, 2017-2020.
Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Six Delays Model: expanding the three delays model with evidence from Madagascar for maternal referrals in LMICs.BMJ global health · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLike other countries in sub-Saharan Africa, Madagascar has a high burden of maternal and neonatal mortality. However, as the proportion of foetal and placental abnormalities among the Malagasy population is unknown, strategies aimed at reducing maternal and neonatal mortality are challenging to define and implement.
methodsWe conducted a multi-year, cross-sectional study using secondary NGO data on obstetric ultrasound, including patient records of all pregnant women who received an obstetric ultrasound screening between July 1st, 2017, and September 30th, 2020, at 62 public-sector primary care facilities in urban and rural regions of Madagascar. We analysed demographic characteristics and determined the prevalence of foetal and placental abnormalities.
resultsThe dataset included 38,688 ultrasound screening reports from 35,919 women, where 2,587/35,919 (7.20%) women had more than one ultrasound exam. Most women (68.63%, 26,550/38,688) received their first ultrasound during the third trimester of pregnancy. Foetal malpresentation at 36 weeks of gestation or later was diagnosed in 5.48% (176/3,211) of women with the breech presentation being most common (breech 3.99%, 128/3,211; transverse 0.84%, 27/3,211; mobile 0.5%, 16/3,211; oblique 0.16%, 5/3,211). Placenta previa was found in 2.31% (875/38,755) and multiple gestations in 1.03% (370/35,919) cases. Around one in every 150 women (0.66%, 234/38,702) had amniotic fluid disorders.
conclusionThe proportion of foetal and placental abnormalities detected by obstetric ultrasound is consistent with findings from other countries in sub-Saharan Africa. In contrast to current WHO recommendations, pregnant women, particularly those from rural, resource-constrained settings attend obstetric ultrasound screenings most commonly during their third trimester of pregnancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.